Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 106.11 K298.05 K128.08 K284.48 K 816.71 K Research & development ———— — Operating income -106.11 K-298.05 K-128.08 K-284.48 K -816.71 K Non-Operating Income, Total 187.42 K——— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 187.42 K——— — Unusual income/expense ———— — Pretax income 81.31 K-298.05 K-128.08 K-284.48 K -629.29 K Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 81.56 K2.38 M2.29 M1.99 M 6.75 M Discontinued operations ———— — Net income 81.56 K2.38 M2.29 M1.99 M 6.75 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 81.56 K2.38 M2.35 M1.99 M 6.8 M Basic earnings per share (Basic EPS) 0.040.320.640.12 1.12 Diluted earnings per share (Diluted EPS) 0.040.320.60.24 1.2 Average basic shares outstanding 14.18 M30.71 M38.91 M63.25 M — Diluted shares outstanding 14.18 M31.74 M39.68 M31.63 M — EBITDA ———— — EBIT -105.86 K-291.59 K-120.6 K-278.55 K -796.61 K Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —